New hope for kids with rare calcium disease
NCT ID NCT07080385
Summary
This study is testing a drug called encaleret in children from birth to age 17 who have a rare inherited condition called Autosomal Dominant Hypocalcemia Type 1 (ADH1). ADH1 causes low blood calcium and related health problems. The main goals are to see how the child's body processes the drug, if it helps control their calcium levels, and if it is safe for them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nemours Children's Health
RECRUITINGJacksonville, Florida, 32207, United States
-
Royal London Hospital
RECRUITINGLondon, E1 1FR, United Kingdom
-
Royal Manchester Children's Hospital
RECRUITINGManchester, M13 9WL, United Kingdom
-
The Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Yale University
RECRUITINGNew Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.